Profile change history

What changed for Cerebrolysin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Cerebrolysin identity.

47Total events
47Record additions
0Version changes
12Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 47 connected records →

Showing the latest 47 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 17, 2026.

Record added

Longitudinal Serum and Cerebrospinal Fluid S100B Concentrations After Aneurysmal Subarachnoid Hemorrhage: An Exploratory Comparison of Historical Cohorts With and Without Cerebrolysin Exposure.

PubMed lists PMID 43030876 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 17, 2026
Cited source date
November 14, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT00840671

PeptideScanner retained ClinicalTrials.gov record NCT00840671 at 2026-11-16T17:33:14.861Z. Its registry update date was 2010-12-28, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
December 28, 2010
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00868283

PeptideScanner retained ClinicalTrials.gov record NCT00868283 at 2026-11-16T17:33:14.861Z. Its registry update date was 2023-12-15, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
December 15, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00947531

PeptideScanner retained ClinicalTrials.gov record NCT00947531 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-02-21, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
February 21, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01059461

PeptideScanner retained ClinicalTrials.gov record NCT01059461 at 2026-11-16T17:33:14.861Z. Its registry update date was 2013-09-13, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
September 13, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01388738

PeptideScanner retained ClinicalTrials.gov record NCT01388738 at 2026-11-16T17:33:14.861Z. Its registry update date was 2011-12-23, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
December 23, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02149875

PeptideScanner retained ClinicalTrials.gov record NCT02149875 at 2026-11-16T17:33:14.861Z. Its registry update date was 2020-08-24, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
August 24, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02768571

PeptideScanner retained ClinicalTrials.gov record NCT02768571 at 2026-11-16T17:33:14.861Z. Its registry update date was 2019-09-20, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03480698

PeptideScanner retained ClinicalTrials.gov record NCT03480698 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-02-25, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
February 25, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03506841

PeptideScanner retained ClinicalTrials.gov record NCT03506841 at 2026-11-16T17:33:14.861Z. Its registry update date was 2021-03-15, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
March 15, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04427241

PeptideScanner retained ClinicalTrials.gov record NCT04427241 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
May 11, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04751136

PeptideScanner retained ClinicalTrials.gov record NCT04751136 at 2026-11-16T17:33:14.861Z. Its registry update date was 2021-02-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
February 11, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04830943

PeptideScanner retained ClinicalTrials.gov record NCT04830943 at 2026-11-16T17:33:14.861Z. Its registry update date was 2023-01-03, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
January 3, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05288465

PeptideScanner retained ClinicalTrials.gov record NCT05288465 at 2026-11-16T17:33:14.861Z. Its registry update date was 2022-03-21, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
March 21, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05755997

PeptideScanner retained ClinicalTrials.gov record NCT05755997 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-02-25, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
February 25, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05807503

PeptideScanner retained ClinicalTrials.gov record NCT05807503 at 2026-11-16T17:33:14.861Z. Its registry update date was 2023-04-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
April 11, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05821075

PeptideScanner retained ClinicalTrials.gov record NCT05821075 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-07-31, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
July 31, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06052787

PeptideScanner retained ClinicalTrials.gov record NCT06052787 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-11-19, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
November 19, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06208540

PeptideScanner retained ClinicalTrials.gov record NCT06208540 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-08-05, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
August 5, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06339411

PeptideScanner retained ClinicalTrials.gov record NCT06339411 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
August 11, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06677502

PeptideScanner retained ClinicalTrials.gov record NCT06677502 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-12-31, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
December 31, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07846488

PeptideScanner retained ClinicalTrials.gov record NCT07846488 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
September 29, 2026
Evidence lane
Clinical trials
Record added

Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study.

PubMed lists PMID 11738849 in Brain & development as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2001-12 (month precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 31, 2022
Evidence lane
Literature metadata
Record added

Cerebrolysin: a review of its use in dementia.

PubMed lists PMID 19848437 in Drugs & aging as Journal Article, Review, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 11, 2026
Evidence lane
Literature metadata
Record added

Cerebrolysin for acute ischaemic stroke.

PubMed lists PMID 20393954 in The Cochrane database of systematic reviews as Journal Article, Systematic Review, with publication-date metadata of 2010-04-14 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 26, 2025
Evidence lane
Literature metadata
Record added

[Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus].

PubMed lists PMID 21350421 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2011 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 25, 2016
Evidence lane
Literature metadata
Record added

Cerebrolysin for vascular dementia.

PubMed lists PMID 23440834 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2013-01-31 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 11, 2025
Evidence lane
Literature metadata
Record added

[Cerebrolysin for acute ischemic stroke].

PubMed lists PMID 23805635 in Vestnik Rossiiskoi akademii meditsinskikh nauk as Journal Article, Review, with publication-date metadata of 2013 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
April 27, 2026
Evidence lane
Literature metadata
Record added

The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for neuroprotection with Cerebrolysin therapy.

PubMed lists PMID 24730284 in Journal of nanoscience and nanotechnology as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2014-01 (month precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 15, 2019
Evidence lane
Literature metadata
Record added

[Cerebrolysin in the treatment of brain injuries of moderate severity].

PubMed lists PMID 25591645 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2014 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 25, 2016
Evidence lane
Literature metadata
Record added

Cerebrolysin for acute ischaemic stroke.

PubMed lists PMID 26083192 in The Cochrane database of systematic reviews as Journal Article, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2015-06-17 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 11, 2025
Evidence lane
Literature metadata
Record added

Cerebrolysin for acute ischaemic stroke.

PubMed lists PMID 27918088 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2016-12-05 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 26, 2025
Evidence lane
Literature metadata
Record added

Cerebrolysin for acute ischaemic stroke.

PubMed lists PMID 28430363 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2017-04-21 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 23, 2025
Evidence lane
Literature metadata
Record added

Role of Cerebrolysin in cervical spondylotic myelopathy patients: a prospective randomized study.

PubMed lists PMID 29155000 in The spine journal : official journal of the North American Spine Society as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017-11-14 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
February 21, 2019
Evidence lane
Literature metadata
Record added

Cerebrolysin: a multi-target drug for recovery after stroke.

PubMed lists PMID 30004268 in Expert review of neurotherapeutics as Journal Article, Review, with publication-date metadata of 2018-07-18 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 9, 2019
Evidence lane
Literature metadata
Record added

Cerebrolysin for vascular dementia.

PubMed lists PMID 31710397 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2019-11-11 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 2, 2024
Evidence lane
Literature metadata
Record added

Cerebrolysin for acute ischaemic stroke.

PubMed lists PMID 32662068 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2020-07-14 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 30, 2025
Evidence lane
Literature metadata
Record added

Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use.

PubMed lists PMID 32808294 in Medicinal research reviews as Journal Article, Review, with publication-date metadata of 2020-08-17 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 28, 2021
Evidence lane
Literature metadata
Record added

Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine.

PubMed lists PMID 33223037 in Progress in brain research as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2020-11-09 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 24, 2021
Evidence lane
Literature metadata
Record added

Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series.

PubMed lists PMID 33620612 in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology as Journal Article, Meta-Analysis, with publication-date metadata of 2021-02-23 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 10, 2026
Evidence lane
Literature metadata
Record added

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis.

PubMed lists PMID 36979317 in Brain sciences as Journal Article, Review, with publication-date metadata of 2023-03-17 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 31, 2023
Evidence lane
Literature metadata
Record added

Noninvasive monitoring in a patient with SAH diagnosis treated with Cerebrolysin - case report and review of the literature.

PubMed lists PMID 37522695 in European review for medical and pharmacological sciences as Review, Case Reports, Journal Article, with publication-date metadata of 2023-07 (month precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 21, 2023
Evidence lane
Literature metadata
Record added

Cerebrolysin for acute ischaemic stroke.

PubMed lists PMID 37818733 in The Cochrane database of systematic reviews as Systematic Review, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-10-11 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 26, 2025
Evidence lane
Literature metadata
Record added

Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.

PubMed lists PMID 37892776 in Journal of clinical medicine as Journal Article, Review, with publication-date metadata of 2023-10-20 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 21, 2026
Evidence lane
Literature metadata
Record added

The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts.

PubMed lists PMID 39832667 in Neuroscience as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-01-19 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 7, 2026
Evidence lane
Literature metadata
Record added

[Cerebrolysin with reperfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CEREHETIS trial].

PubMed lists PMID 40577185 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Journal Article, Randomized Controlled Trial, English Abstract, with publication-date metadata of 2025 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 3, 2025
Evidence lane
Literature metadata
Record added

Cerebroprotection in acute ischemic stroke: Perspectives on combining cerebrolysin with recanalization therapy.

PubMed lists PMID 41349847 in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association as Journal Article, Review, with publication-date metadata of 2025-12-03 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 10, 2026
Evidence lane
Literature metadata